Rankings
▼
Calendar
KMDA Q4 2018 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q4 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$48M
+35.0% YoY
Gross Profit
$21M
44.1% margin
Operating Income
$15M
31.9% margin
Net Income
$18M
36.8% margin
EPS (Diluted)
$0.44
QoQ Revenue Growth
+221.9%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$6M
Stock-Based Comp.
$269,000
Balance Sheet
Total Assets
$138M
Total Liabilities
$26M
Stockholders' Equity
$112M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$48M
$36M
+35.0%
Gross Profit
$21M
$12M
+82.8%
Operating Income
$15M
$6M
+138.7%
Net Income
$18M
$6M
+183.8%
← FY 2018
All Quarters
Q1 2019 →